Hybrisan has been acquired by Eumar
Cardiff – CFI is pleased to announce that it acted as exclusive financial advisor with Hybrisan on its sale to Eumar Technology.
Hybrisan, founded in 2013, has built a strong reputation in chronic wound care. Its lead product, WoundSan®, is a clinically evidenced wound cleansing technology currently progressing through EU MDR approval and expected to reach the market later this year. Hybrisan will continue to operate from its headquarters in Port Talbot, with increased investment from its new owners in its South Wales innovation hub.
Founded in 1985 and headquartered in Hereford, Eumar Technology is a specialist medical device manufacturer serving the global wound care market.
This move establishes a clearly defined and complementary structure, combining Eumar Technology’s ISO 13485-certified manufacturing facilities and superabsorbent materials expertise with Hybrisan’s product development expertise in electrospinning and antimicrobials.
Chris Mortimer, Chief Technology Officer (formerly CEO, Hybrisan): “Combining Hybrisan’s development expertise with Eumar’s manufacturing capability, infrastructure and commercial reach will allow us to accelerate innovative wound care solutions to market. The continuation of operations in Port Talbot ensures the specialist skills we have built in South Wales remain central to the group’s future.”
Euan Davidson, Chairman, Eumar Technology: “This acquisition is central to our long-term strategy to build a leading UK medical device business. We are committed to investing in skilled employment and manufacturing excellence across both Herefordshire and South Wales, with the goal of creating a CDMO recognised internationally for taking innovative products from concept to commercial manufacture entirely within the United Kingdom.”
This transaction closed on 5 June 2026.
Healthcare & Life Sciences

has been acquired by

Transaction details
Hybrisan, a MedTech company founded to solve problems of bioburden and biofilm in healthcare, has been acquired by Eumar Technology
This transaction was advised by:

Frank Holmes
Partner, Managing Director
Sam Forman
Partner, Managing DirectorOur latest transactions
Software & IT Services

has been acquired by

Transaction details
Insurance technology company IS2 has been acquired by SSP
Consumer Goods & Retail

has become majority-owned by

Transaction details
French premium tea house Kusmi Tea is now majority-owned by Nextworld via a €22m capital raise, including €10m in bank debt
Consumer Goods & Retail

has agreed to sell

to

Transaction details
L'Occitane Group has sold British prestige skincare brand Elemis to PAI Partners
Software & IT Services

has been acquired by

Transaction details
Stockholm Internet eXchange has been acquired by European Internet Exchange operator NL-ix